Delivery Order SPE2DB22D2007-SPE2DB24FJ6FM

Award Date 9/18/24
Potential Completion Date 9/19/24
Potential Value $6.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,589.63 contract is for the provision of 4,564,186,162 units of Telmisartan 80 mg tablets. This delivery order falls under a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply Telmisartan 80 mg tablets. The $3,263.89 contract has an ultimate completion date of April 8, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025....
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $2,531.37 to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4,565,089,797 units of the pharmaceutical drug Telmisartan 80 mg Tablet 30s. The contract has an ultimate completion date of July 9, 2024 and was awarded on July 8, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 that AmerisourceBergen holds...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $1,845.14 to Amerisourcebergen Drug Corp's Corporate Office Division on June 7, 2024. The contract is for the supply of Telmisartan 80 mg tablets in 30-count packages, with a completion date of June 10, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999.00 and runs through December...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,088.15 to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of Telmisartan 80 mg tablets in 30-count packages, with a completion date of February 28, 2024. This delivery order does not have a set-aside designation and is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $1,809.12 to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor. The contract is for the supply of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 2025. Under...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $16,557.69 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Telmisartan-HCTZ 80-25 mg tablets in 30-count packages. The contract has a performance period through March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and a performance...
The U.S. government awarded a Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Telmisartan 20 mg tablets. This $1,520.60 Firm Fixed Price contract was issued by the Defense Logistics Agency (DLA) Troop Support Medical and has a period of performance through February 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract with the DLA Troop Support Medical that...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,160.70 firm fixed-price delivery order is for the supply of Telmisartan 80 mg tablets, a cardiovascular medication. The contract has an ultimate completion date of November 20, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,139.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan 80 mg tablets, a medication used to treat high blood pressure. The award has an ultimate completion date of December 4, 2024 and is structured as a Firm Fixed Price Delivery Order. The contract is not designated with a set-aside requirement,...
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB24FJ6FM
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $6,593.82 Delivery Order contract to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets. This contract has a period of performance through September 19, 2024 and is a Firm Fixed Price agreement. AmerisourceBergen, a major pharmaceutical distributor, is providing these essential medications to support DLA Troop Support Medical's mission of supplying medical commodities to military treatment facilities and other government healthcare programs. This award is part of AmerisourceBergen's large Indefinite Delivery Contract with DLA, valued at up to $999,999,999, which enables the efficient procurement of a comprehensive range of pharmaceutical and medical supplies.

Generated 12/18/24, 9:22 AM